Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Hormone Receptor Positive Breast Carcinoma|Breast Neoplasms|Neoplasms, Breast|Breast Diseases|Antineoplastic Agents|Aromatase Inhibitors|ESR1 Gene Mutation
Interventions: DIAGNOSTIC_TEST: Liquid biopsy and CT scan
Sponsor: Centro di Riferimento Oncologico - Aviano